These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 37727283)
1. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Murphy CK; O'Donnell MM; Hegarty JW; Schulz S; Hill C; Ross RP; Rea MC; Farquhar R; Chesnel L World J Gastrointest Pathophysiol; 2023 Aug; 14(4):71-85. PubMed ID: 37727283 [TBL] [Abstract][Full Text] [Related]
2. Identification of ADS024, a newly characterized strain of Bacillus velezensis with direct Clostridiodes difficile killing and toxin degradation bio-activities. O'Donnell MM; Hegarty JW; Healy B; Schulz S; Walsh CJ; Hill C; Ross RP; Rea MC; Farquhar R; Chesnel L Sci Rep; 2022 Jun; 12(1):9283. PubMed ID: 35662257 [TBL] [Abstract][Full Text] [Related]
3. ADS024, a Xie Y; Chupina Estrada A; Nelson B; Feng H; Pothoulakis C; Chesnel L; Koon HW Front Microbiol; 2022; 13():1072534. PubMed ID: 36704560 [No Abstract] [Full Text] [Related]
4. The role of the gut microbiome in colonization resistance and recurrent Seekatz AM; Safdar N; Khanna S Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection. Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379 [TBL] [Abstract][Full Text] [Related]
6. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities. Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161 [TBL] [Abstract][Full Text] [Related]
7. Wang R Front Microbiol; 2023; 14():1182612. PubMed ID: 37228365 [No Abstract] [Full Text] [Related]
8. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis. Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107 [TBL] [Abstract][Full Text] [Related]
10. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection. Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769 [TBL] [Abstract][Full Text] [Related]
11. 2'-Fucosyllactose inhibits proliferation of Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156 [TBL] [Abstract][Full Text] [Related]
12. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes. Lesniak NA; Schubert AM; Sinani H; Schloss PD mSphere; 2021 May; 6(3):. PubMed ID: 33952668 [TBL] [Abstract][Full Text] [Related]